Literature DB >> 33515600

Oncogenic mutations on Rac1 affect global intrinsic dynamics underlying GTP and PAK1 binding.

Saliha Ece Acuner1, Fidan Sumbul1, Hamdi Torun2, Turkan Haliloglu3.   

Abstract

Rac1 is a small member of the Rho GTPase family. One of the most important downstream effectors of Rac1 is a serine/threonine kinase, p21-activated kinase 1 (PAK1). Mutational activation of PAK1 by Rac1 has oncogenic signaling effects. Here, although we focus on Rac1-PAK1 interaction by atomic-force-microscopy-based single-molecule force spectroscopy experiments, we explore the effect of active mutations on the intrinsic dynamics and binding interactions of Rac1 by Gaussian network model analysis and molecular dynamics simulations. We observe that Rac1 oncogenic mutations are at the hinges of three global modes of motion, suggesting the mechanical changes as potential markers of oncogenicity. Indeed, the dissociation of wild-type Rac1-PAK1 complex shows two distinct unbinding dynamic states that are reduced to one with constitutively active Q61L and oncogenic Y72C mutant Rac1, as revealed by single-molecule force spectroscopy experiments. Q61L and Y72C mutations change the mechanics of the Rac1-PAK1 complex by increasing the elasticity of the protein and slowing down the transition to the unbound state. On the other hand, Rac1's intrinsic dynamics reveal more flexible GTP and PAK1-binding residues on switches I and II with Q61L, Y72C, oncogenic P29S and Q61R, and negative T17N mutations. The cooperativity in the fluctuations of GTP-binding sites around the p-loop and switch I decreases in all mutants, mostly in Q61L, whereas some PAK1-binding residues display enhanced coupling with GTP-binding sites in Q61L and Y72C and within each other in P29S. The predicted binding free energies of the modeled Rac1-PAK1 complexes show that the change in the dynamic behavior likely means a more favorable PAK1 interaction. Overall, these findings suggest that the active mutations affect intrinsic functional dynamic events and alter the mechanics underlying the binding of Rac1 to GTP and upstream and downstream partners including PAK1.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33515600      PMCID: PMC8008323          DOI: 10.1016/j.bpj.2021.01.016

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  56 in total

Review 1.  Regulation of the cytoskeleton by Rho-family GTPases: implications for tumour cell invasion.

Authors:  L S Price; J G Collard
Journal:  Semin Cancer Biol       Date:  2001-04       Impact factor: 15.707

2.  Structure of Cdc42 bound to the GTPase binding domain of PAK.

Authors:  A Morreale; M Venkatesan; H R Mott; D Owen; D Nietlispach; P N Lowe; E D Laue
Journal:  Nat Struct Biol       Date:  2000-05

Review 3.  Biology of the p21-activated kinases.

Authors:  Gary M Bokoch
Journal:  Annu Rev Biochem       Date:  2003-03-27       Impact factor: 23.643

4.  Inference of macromolecular assemblies from crystalline state.

Authors:  Evgeny Krissinel; Kim Henrick
Journal:  J Mol Biol       Date:  2007-05-13       Impact factor: 5.469

5.  Specific roles of Rac1 and Rac2 in motile functions of HT1080 fibrosarcoma cells.

Authors:  Verena Niggli; Dominique Schlicht; Sarah Affentranger
Journal:  Biochem Biophys Res Commun       Date:  2009-06-23       Impact factor: 3.575

6.  The Catalogue of Somatic Mutations in Cancer (COSMIC).

Authors:  S A Forbes; G Bhamra; S Bamford; E Dawson; C Kok; J Clements; A Menzies; J W Teague; P A Futreal; M R Stratton
Journal:  Curr Protoc Hum Genet       Date:  2008-04

7.  FiberDock: a web server for flexible induced-fit backbone refinement in molecular docking.

Authors:  Efrat Mashiach; Ruth Nussinov; Haim J Wolfson
Journal:  Nucleic Acids Res       Date:  2010-05-11       Impact factor: 16.971

8.  A critical role for Rac1 in tumor progression of human colorectal adenocarcinoma cells.

Authors:  Carolina Espina; María Virtudes Céspedes; Miguel Angel García-Cabezas; María Teresa Gómez del Pulgar; Alicia Boluda; Lourdes García Oroz; Salvador A Benitah; Paloma Cejas; Manuel Nistal; Ramón Mangues; Juan Carlos Lacal
Journal:  Am J Pathol       Date:  2007-12-28       Impact factor: 4.307

9.  Rho GTPases. Integrating integrin signaling.

Authors:  A Ridley
Journal:  J Cell Biol       Date:  2000-08-21       Impact factor: 10.539

Review 10.  Deregulation of Rho GTPases in cancer.

Authors:  Andrew P Porter; Alexandra Papaioannou; Angeliki Malliri
Journal:  Small GTPases       Date:  2016-04-22
View more
  4 in total

1.  Convergent Alterations of a Protein Hub Produce Divergent Effects within a Binding Site.

Authors:  Ali Imran; Brandon S Moyer; Dan Kalina; Thomas M Duncan; Kelsey J Moody; Aaron J Wolfe; Michael S Cosgrove; Liviu Movileanu
Journal:  ACS Chem Biol       Date:  2022-05-25       Impact factor: 4.634

Review 2.  Rac1 as a Target to Treat Dysfunctions and Cancer of the Bladder.

Authors:  Vincent Sauzeau; Julien Beignet; Christian Bailly
Journal:  Biomedicines       Date:  2022-06-08

3.  Q61 mutant-mediated dynamics changes of the GTP-KRAS complex probed by Gaussian accelerated molecular dynamics and free energy landscapes.

Authors:  Jianzhong Chen; Qingkai Zeng; Wei Wang; Qingquan Hu; Huayin Bao
Journal:  RSC Adv       Date:  2022-01-11       Impact factor: 3.361

Review 4.  Rac1, A Potential Target for Tumor Therapy.

Authors:  Jiaxin Liang; Linda Oyang; Shan Rao; Yaqian Han; Xia Luo; Pin Yi; Jinguan Lin; Longzheng Xia; Jiaqi Hu; Shiming Tan; Lu Tang; Qing Pan; Yanyan Tang; Yujuan Zhou; Qianjin Liao
Journal:  Front Oncol       Date:  2021-05-17       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.